A Phase III Multi-centre Randomised, Double Blind, Placebo Controlled Trial to Assess the Role of Intravenous Immunoglobulin in the Management of Children With Encephalitis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 21 Oct 2017
At a glance
- Drugs Immune globulin (Primary)
- Indications Encephalitis
- Focus Therapeutic Use
- Acronyms IgNiTE
- 10 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 28 Jan 2016 Status changed from not yet recruiting to recruiting as per United Kingdom Clinical Research Network record.
- 09 Dec 2014 New trial record